tweenvest

Kardigan, Inc. (NasdaqGM: KARD)

Health Care · Pharmaceuticals · US

$13.82

-2.12% today · -37.2% 1Y

Public summary
A free snapshot of Kardigan, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Kardigan, Inc. (NasdaqGM: KARD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.29B and employs 241 people.

Over the last twelve months the share price has lost 37.2%, trading between 12.23 and 27.00.

Tweenvest scores Kardigan, Inc. across four factors: quality 46/100, value 100/100. Its strongest factor is value.

KARD price history

Jun 18, 2026 · 22.00Weekly closes 12.80 – 24.64Nov 13, 2026 · 13.82

Key figures

Market cap
$1.29B
Revenue (TTM)
—
P/E
-4.48
EPS
-17.23
Dividend yield
—
Beta (5Y)
—
52-week high
$27.00
52-week low
$12.23
Avg volume (3M)
—
Shares outstanding
93.60M
Employees
241
Next earnings
—

About Kardigan, Inc.

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.

ISIN
US4859251013
Founded
2023
Listed since
Jun 18, 2026
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
Green Thumb Industries Inc.CNSX: GTII$1.31BCA$8.59+0.12%
Innoviva, Inc.NasdaqGS: INVA$1.31B$18.40+0.55%
Ocular Therapeutix, Inc.NasdaqGM: OCUL$1.31B$5.94-1.16%
Zhejiang Hisoar Pharmaceutical Co., Ltd.SZSE: 002099$1.29BCN¥5.61-2.26%
Amphastar Pharmaceuticals, Inc.NasdaqGS: AMPH$1.27B$29.71+2.10%
Omeros CorporationNasdaqGM: OMER$1.27B$17.49-2.78%
Zhejiang Jolly Pharmaceutical Co.,LTDSZSE: 300181$1.26BCN¥12.05-1.47%
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.SHSE: 688076$1.25BCN¥26.42-2.94%

Browse every Pharmaceuticals company →